251 related articles for article (PubMed ID: 23498955)
1. HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex.
Zona L; Lupberger J; Sidahmed-Adrar N; Thumann C; Harris HJ; Barnes A; Florentin J; Tawar RG; Xiao F; Turek M; Durand SC; Duong FH; Heim MH; Cosset FL; Hirsch I; Samuel D; Brino L; Zeisel MB; Le Naour F; McKeating JA; Baumert TF
Cell Host Microbe; 2013 Mar; 13(3):302-13. PubMed ID: 23498955
[TBL] [Abstract][Full Text] [Related]
2. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
Baktash Y; Madhav A; Coller KE; Randall G
Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.
Diao J; Pantua H; Ngu H; Komuves L; Diehl L; Schaefer G; Kapadia SB
J Virol; 2012 Oct; 86(20):10935-49. PubMed ID: 22855500
[TBL] [Abstract][Full Text] [Related]
4. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J
J Virol; 2018 May; 92(10):. PubMed ID: 29491159
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus induces CD81 and claudin-1 endocytosis.
Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA
J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146
[TBL] [Abstract][Full Text] [Related]
6. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
[TBL] [Abstract][Full Text] [Related]
7. Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection.
Meyer K; Kwon YC; Liu S; Hagedorn CH; Ray RB; Ray R
Sci Rep; 2015 Mar; 5():9012. PubMed ID: 25757571
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Virus Entry: Protein Interactions and Fusion Determinants Governing Productive Hepatocyte Invasion.
Gerold G; Moeller R; Pietschmann T
Cold Spring Harb Perspect Med; 2020 Feb; 10(2):. PubMed ID: 31427285
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus entry and the tetraspanin CD81.
Farquhar MJ; Harris HJ; McKeating JA
Biochem Soc Trans; 2011 Apr; 39(2):532-6. PubMed ID: 21428934
[TBL] [Abstract][Full Text] [Related]
10. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
[TBL] [Abstract][Full Text] [Related]
11. CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.
Zona L; Tawar RG; Zeisel MB; Xiao F; Schuster C; Lupberger J; Baumert TF
Viruses; 2014 Feb; 6(2):875-92. PubMed ID: 24553110
[TBL] [Abstract][Full Text] [Related]
12. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
[TBL] [Abstract][Full Text] [Related]
13. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
[TBL] [Abstract][Full Text] [Related]
14. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.
Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF
Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648
[TBL] [Abstract][Full Text] [Related]
16. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
[TBL] [Abstract][Full Text] [Related]
17. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.
Lupberger J; Zeisel MB; Xiao F; Thumann C; Fofana I; Zona L; Davis C; Mee CJ; Turek M; Gorke S; Royer C; Fischer B; Zahid MN; Lavillette D; Fresquet J; Cosset FL; Rothenberg SM; Pietschmann T; Patel AH; Pessaux P; Doffoël M; Raffelsberger W; Poch O; McKeating JA; Brino L; Baumert TF
Nat Med; 2011 May; 17(5):589-95. PubMed ID: 21516087
[TBL] [Abstract][Full Text] [Related]
18. How hepatitis C virus invades hepatocytes: the mystery of viral entry.
Zhu YZ; Qian XJ; Zhao P; Qi ZT
World J Gastroenterol; 2014 Apr; 20(13):3457-67. PubMed ID: 24707128
[TBL] [Abstract][Full Text] [Related]
19. Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids.
So CW; Sourisseau M; Sarwar S; Evans MJ; Randall G
PLoS Pathog; 2023 Dec; 19(12):e1011887. PubMed ID: 38157366
[TBL] [Abstract][Full Text] [Related]
20. Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.
Kachko A; Costafreda MI; Zubkova I; Jacques J; Takeda K; Wells F; Kaplan G; Major ME
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
